» Articles » PMID: 38861014

In Vitro Effect of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) on the Expression of Genes Related to Sperm Motility and Energy Metabolism and Intracytoplasmic Sperm Injection Outcomes in Obstructive Azoospermic Patients

Overview
Journal Mol Biol Rep
Specialty Molecular Biology
Date 2024 Jun 11
PMID 38861014
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The presence of granulocyte-macrophage colony-stimulating factor (GM-CSF) and its receptor in various testicular cells and spermatozoa suggests a potential role in enhancing spermatogonial and postmeiotic cell development. Moreover, GM-CSF activates the pivotal pathways implicated in sperm motility regulation and glucose metabolism. However, the impact of GM-CSF on testicular biopsies from patients with obstructive azoospermia (OA) remains unexplored. Therefore, this study aimed to investigate the in vitro effects of GM-CSF on the expression of genes related to glucose transporters and signaling pathways, sperm motility, and viability in testicular biopsies.

Methods And Results: Following testicular sperm extraction from 20 patients diagnosed with OA, each sample was divided into two parts: the experimental samples were incubated with medium containing 2 ng/ml GM-CSF at 37 °C for 60 min, and the control samples were incubated with medium without GM-CSF. Subsequently, the oocytes retrieved from the partner were injected with sperm from the treatment and control groups. The sperm parameters (motility and viability), the expression levels of sperm motility-related genes (PIK3R1, PIK3CA, and AKT1), and the expression levels of sperm energy metabolism-related genes (GLUT1, GLUT3, and GLUT14) were assessed. Furthermore, the fertilization and day 3 embryo development rate and embryo quality were evaluated. Compared with those in the nontreated group, the motility parameters and the mRNA expression levels of PIK3R1, AKT1, and GLUT3 in testicular sperm supplemented with GM-CSF were significantly greater (p < 0.05). However, no significant differences in the mRNA expression of PIK3CA, GLUT1, or GLUT14 were detected. According to the ICSI results, compared with the control group, the GM-CSF treatment group exhibited significantly greater fertilization rates (p = 0.027), Day 3 embryo development rate (p = 0.001), and proportions of good-quality embryos (p = 0.002).

Conclusions: GM-CSF increased the expression of genes related to motility and the energy metabolism pathway and effectively promoted the motility of testis-extracted spermatozoa, consequently yielding positive clinical outcomes.

References
1.
Moein M, Moein M, Ghasemzadeh J, Pourmasoumi S . Evaluation of sperm retrieval rate with bilateral testicular sperm extraction in infertile patients with azoospermia. Iran J Reprod Med. 2016; 13(11):711-4. PMC: 4695686. View

2.
Schill T, Bals-Pratsch M, Kupker W, Sandmann J, Johannisson R, Diedrich K . Clinical and endocrine follow-up of patients after testicular sperm extraction. Fertil Steril. 2003; 79(2):281-6. DOI: 10.1016/s0015-0282(02)04663-0. View

3.
Nagy Z, Liu J, Joris H, Verheyen G, Tournaye H, Camus M . The result of intracytoplasmic sperm injection is not related to any of the three basic sperm parameters. Hum Reprod. 1995; 10(5):1123-9. DOI: 10.1093/oxfordjournals.humrep.a136104. View

4.
Ortega C, Verheyen G, Raick D, Camus M, Devroey P, Tournaye H . Absolute asthenozoospermia and ICSI: what are the options?. Hum Reprod Update. 2011; 17(5):684-92. DOI: 10.1093/humupd/dmr018. View

5.
Stalf T, Mehnert C, Hajimohammad A, Manolopoulos K, Shen Y, Schuppe H . Influence of motility and vitality in intracytoplasmic sperm injection with ejaculated and testicular sperm. Andrologia. 2005; 37(4):125-30. DOI: 10.1111/j.1439-0272.2005.00665.x. View